This document provides guidance on the clinical development of new medicinal products in the treatment of migraine.
Keywords: Migraine, acute migraine, chronic migraine, migraine prophylaxis
Current effective version
Guideline on clinical investigation of medicinal products for the treatment of migraine
English (EN) (66.73 KB - PDF)
Document history
Concept paper on the need for revision of the guideline on clinical investigation of medicinal product for the treatment of migraine
English (EN) (84.58 KB - PDF)
Guideline on clinical investigation of medicinal products for the treatment of migraine
English (EN) (66.73 KB - PDF)
Overview of comments received on draft guideline on clinical investigation of medicinal products for the treatment of migraine
English (EN) (56.57 KB - PDF)
Draft guideline on clinical investigation of medicinal products for the treatment of migraine
English (EN) (77.46 KB - PDF)
Related content
- Clinical efficacy and safety: nervous system
- Directive 2001/83/EC
- Application with 1. Meta-analyses; 2. One pivotal study
- ICH E1 Population exposure: the extent of population exposure to assess clinical safety
- ICH E4 Dose response information to support drug registration
- ICH E8 General considerations for clinical studies
- ICH E9 statistical principles for clinical trials
- ICH E10 Choice of control group in clinical trials
- ICH E11(R1) step 5 guideline on clinical investigation of medicinal products in the pediatric population - Scientific guideline
- Investigation of drug interactions
- Multiplicity issues in clinical trials
- Pharmacokinetic studies in man